What is the prevalence of Hereditary Angioedema?

The estimated prevalence of Hereditary Angioedema (HAE) ranges from 1 in 10,000 to 1 in 50,000 individuals worldwide, though these figures are likely underestimates due to significant historical underdiagnosis.

Epidemiological Overview

Hereditary Angioedema is classified as a rare genetic disorder. While incidence rates are difficult to track precisely because many patients remain undiagnosed for years, clinical literature suggests that the condition affects males and females equally. Symptoms of Hereditary Angioedema typically begin in childhood or adolescence, often worsening during puberty, though the age of onset can vary significantly even among family members sharing the same genetic mutation.

Challenges in Data Collection

Accurate prevalence data for Hereditary Angioedema is hampered by the fact that many patients are initially misdiagnosed with common allergies or idiopathic urticaria. Because it is a rare disease, many primary care physicians may not encounter a case throughout their entire career, leading to delays in referral to specialized allergologists or immunologists. There is no significant evidence of geographic or ethnic bias; the condition appears to be distributed globally across all populations.

Community Perspectives

While formal epidemiological studies provide a baseline, the 423 individuals living with Hereditary Angioedema who have joined the DiseaseMaps.org community offer a vital, real-world perspective on the burden of this disease. This data helps researchers understand the patient journey—from the initial onset of swelling to the eventual diagnosis—highlighting that the true clinical impact of Hereditary Angioedema is often greater than static prevalence numbers suggest.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• OMIM (Online Mendelian Inheritance in Man)